Aptose Biosciences (APTO) announced dosing the first set of patients in the TUSCANY Phase 1/2 study with tuspetinib in combination with ...

Researchers sought to assess the risk of developing ALL in patients with multiple myeloma treated with lenalidomide.

Acute myeloid leukemia (AML) is an aggressive bone marrow disease. Despite advances in treatment, AML remains a therapeutic challenge due to high rates of ...

Biotherapeutics company PureTech Health plc (PRTC) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted ...

A study published in the journal Molecules highlights the potential of two cannabis-derived compounds, cannabinol (CBN) and cannabigerol (CBG), in combating acute myeloid leukemia. “Several cannabis ...

Changes in Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes Dec. 5 ... could have implications for the treatment of acute myeloid leukemia and ...

Hyperleukocytosis is often seen in monocytic variants and can be ... DIC is also observed in patients with AML, in particular, acute promyelocytic leukemia (APL or M3-AML). These patients are ...

Katie Melua has opened up about suffering an acute psychotic breakdown earlier in her career, attributing it to the pressures of the music industry and touring. READ MORE: “Pressure cooker ...

It is typically seen with advanced leukemia or a form of the disease called acute myeloid leukemia (AML). Only around 2% or 3% of people with leukemia get leukemia cutis. Leukemia cutis causes ...

SAN DIEGO — Brian Koffman found himself in a situation a couple years ago that most chronic lymphocytic leukemia patients eventually do: relapse. The expectation in CLL is that, no matter what ...